arginine vasopressin has been researched along with Huntington Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colwell, CS; Gad, L; Ghiani, CA; Hitchcock, ON; Kuljis, DA; Loh, DH; MacDowell Kaswan, Z | 1 |
Anink, JJ; Aziz, NA; Roos, RA; Swaab, DF; van Wamelen, DJ | 1 |
Angeloni, D; Anink, JJ; Aziz, NA; Fraschini, F; Jockers, R; Roos, RA; Swaab, DF; van Steenhoven, R; van Wamelen, DJ | 1 |
3 other study(ies) available for arginine vasopressin and Huntington Disease
Article | Year |
---|---|
Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease.
Topics: Animals; Arginine Vasopressin; Chromosomes, Artificial, Bacterial; Circadian Rhythm; Disease Models, Animal; Disease Progression; Female; Founder Effect; Gene Expression; Humans; Huntington Disease; Male; Mice; Mice, Transgenic; Motor Activity; Rotarod Performance Test; Sex Factors; Suprachiasmatic Nucleus; Time Factors; Vasoactive Intestinal Peptide | 2016 |
Paraventricular nucleus neuropeptide expression in Huntington's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Arginine Vasopressin; Corticotropin-Releasing Hormone; Female; Humans; Huntington Disease; Male; Middle Aged; Nerve Tissue Proteins; Neurons; Neuropeptides; Oxytocin; Paraventricular Hypothalamic Nucleus; RNA, Messenger; Statistics, Nonparametric | 2012 |
Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease.
Topics: Arginine Vasopressin; Chronobiology Disorders; Circadian Rhythm; Cohort Studies; Female; Humans; Huntington Disease; Hypothalamus; In Situ Hybridization; Male; Neuropeptides; Sleep Wake Disorders; Suprachiasmatic Nucleus; Vasoactive Intestinal Peptide | 2013 |